A van Tol Selected Research

Pre-beta High-Density Lipoproteins

8/2009	Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
2/2008	Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
6/2001	Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
2/2001	Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A van Tol Research Topics

Disease

8	Type 2 Diabetes Mellitus (MODY) 08/2009 - 02/2006
4	Insulin Resistance 01/2007 - 05/2000
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2010 - 02/2001
3	Hypertriglyceridemia 02/2008 - 01/2001
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2005 - 06/2005
2	Atherosclerosis 07/2001 - 01/2001
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2000 - 05/2000
1	Sclerosis 01/2005
1	Overweight 09/2004
1	Body Weight (Weight, Body) 07/2002
1	Hepatocellular Carcinoma (Hepatoma) 06/2001
1	Liver Diseases (Liver Disease) 01/2001
1	Hyperlipidemias (Hyperlipidemia) 01/2001
1	Erythropoietic Protoporphyria 01/2001
1	Acromegaly 12/2000
1	Albuminuria 07/2000
1	Diarrhea 02/2000

Drug/Important Bio-Agent (IBA)

9	CholesterolIBA 02/2008 - 05/2000
7	LipidsIBA 01/2009 - 05/2000
6	HDL CholesterolIBA 01/2009 - 01/2001
5	Phospholipid Transfer ProteinsIBA 08/2009 - 06/2001
4	Pre-beta High-Density LipoproteinsIBA 08/2009 - 02/2001
4	HDL LipoproteinsIBA 03/2009 - 01/2001
4	Lipoproteins (Lipoprotein)IBA 01/2009 - 01/2001
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2010 - 06/2001
3	Atorvastatin (Lipitor)FDA Link 08/2009 - 07/2006
3	Simvastatin (Zocor)FDA LinkGeneric 03/2009 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 01/2009 - 07/2006
3	Insulin (Novolin)FDA Link 02/2006 - 05/2000
3	Cholesterol Esters (Cholesteryl Esters)IBA 02/2001 - 05/2000
2	EnzymesIBA 03/2009 - 01/2001
2	AdiponectinIBA 01/2009 - 01/2007
2	Cholesterol Ester Transfer ProteinsIBA 01/2009 - 01/2007
2	Lipase (Acid Lipase)FDA Link 01/2009 - 02/2001
2	C-Reactive ProteinIBA 01/2007 - 02/2006
2	Blood Glucose (Blood Sugar)IBA 02/2001 - 05/2000
2	Growth Hormone (Somatotropin)IBA 12/2000 - 05/2000
1	ApolipoproteinsIBA 01/2010
1	BezafibrateIBA 03/2009
1	Aryldialkylphosphatase (Paraoxonase)IBA 03/2009
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2009
1	LeptinIBA 01/2007
1	ResistinIBA 01/2007
1	Apolipoprotein A-VIBA 07/2006
1	Phospholipids (Phosphatides)FDA LinkGeneric 02/2006
1	Chylomicron RemnantsIBA 01/2005
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2002
1	Trans Fatty AcidsIBA 07/2002
1	Soybean Oil FDA LinkGeneric 07/2002
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 10/2001
1	Glucose (Dextrose)FDA LinkGeneric 02/2001
1	Heme (Haem)IBA 01/2001
1	Ferrochelatase (Heme Synthetase)IBA 01/2001
1	Angiotensin Receptor AntagonistsIBA 07/2000
1	LDL CholesterolIBA 07/2000
1	GlucocorticoidsIBA 05/2000
1	Cortisone FDA Link 05/2000
1	SteroidsIBA 02/2000

Therapy/Procedure

1	Therapeutics 12/2000